These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8469900)
21. Current advances in sepsis and septic shock with particular emphasis on the role of insulin. Das UN Med Sci Monit; 2003 Aug; 9(8):RA181-92. PubMed ID: 12942044 [TBL] [Abstract][Full Text] [Related]
31. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Wheatley C Med Hypotheses; 2006; 67(1):124-42. PubMed ID: 16545917 [TBL] [Abstract][Full Text] [Related]
32. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131 [TBL] [Abstract][Full Text] [Related]
33. Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Manley MO; O'Riordan MA; Levine AD; Latifi SQ Shock; 2005 Jun; 23(6):521-6. PubMed ID: 15897804 [TBL] [Abstract][Full Text] [Related]
34. [Plasmapheresis in the treatment of septic shock]. Busund R Tidsskr Nor Laegeforen; 2004 Mar; 124(6):776-8. PubMed ID: 15039806 [TBL] [Abstract][Full Text] [Related]
35. The role of endotoxin in human septic shock: therapeutic potential of lipid A analogs. Danner RL; Parrillo JE Prog Clin Biol Res; 1989; 286():183-200. PubMed ID: 2648410 [No Abstract] [Full Text] [Related]
36. Issues in the adjunct therapy of severe sepsis. Verhoef J; Hustinx WM; Frasa H; Hoepelman AI J Antimicrob Chemother; 1996 Aug; 38(2):167-82. PubMed ID: 8877531 [TBL] [Abstract][Full Text] [Related]
37. [Recent clinical trials for sepsis: analysis of the results and future perspectives]. Wakabayashi G; Shimazu M; Tanabe M; Ueda M; Hoshino K; Morikawa Y; Kitajima M Nihon Geka Gakkai Zasshi; 1999 Oct; 100(10):674-8. PubMed ID: 10570778 [TBL] [Abstract][Full Text] [Related]
38. Do monoclonal antibodies and anticytokines still have a future in infectious diseases? Cohen J; Heumann D; Glauser MP Am J Med; 1995 Dec; 99(6A):45S-52S; discussion 52S-53S. PubMed ID: 8585536 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of therapeutic agents: morphologic changes and survival data in dogs subjected to endotoxin during the shock tour. Brunson JG; Schulz DM; Angevine DM; Imrie ST; Douglas BH J Okla State Med Assoc; 1966 Aug; 59(8):477-84. PubMed ID: 5944537 [No Abstract] [Full Text] [Related]